Search

everythinglearnresearchcommunity

for

Search:↓

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

Adipose tissue changes in obesity can trigger stress in fat cells.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

All-trans retinoic acid causes hair loss by increasing TGF-β2 in hair follicle cells.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Radiofrequency exposure can stimulate hair growth by increasing IGF-1 in hair follicle cells.

Mice lacking fibromodulin have disrupted healing patterns, leading to abnormal skin repair and scarring.

Researchers found an RNA transcript that might help control a growth factor linked to tumor development.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Janus Kinase Inhibitors are promising new treatments for various skin conditions due to their effectiveness and safety.

PDGF-BB helps young melanocytes grow but stops mature ones from growing, and it makes melanocytes more specialized.

Actinic keratosis is a sun-induced skin condition that can potentially turn into skin cancer and requires treatment to prevent malignancy.

Aminopterin was somewhat effective in acute lymphoblastic leukemia in children but did not increase survival time.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Human placenta helps hair grow back after chemotherapy by blocking cell death and increasing hair follicle growth.

Physical activity, height, and smoking affect prostate cancer risk.

Adolescents with severe alopecia incur significantly higher healthcare costs.

Quercitrin may help treat hair loss by promoting hair growth and improving cell health.

A blood pressure drug, diltiazem, may also help treat influenza.

Certain amino acid analogues can inhibit wool and hair growth and affect fiber strength.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.